Loading viewer...
investor_presentation
Format: PDF investor_presentation
January 29, 2021 L3HARRIS CY2020 FOURTH QUARTER EARNINGS CALL PRESENTATION
L3HARRIS CY2020 FOURTH QUARTER
EARNINGS CALL PRESENTATION2L3Harris CALENDAR YEAR 2020 FOURTH QUARTER EARNINGS PRESENTATIONStatements in this presentation that are not historical facts are forward-looking statements that reflect management's current expectations, assumptions and estimates of future performance and
economic conditions. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements in this presentation include but are not limited to: revenue, earnings per share, margin, free cash flow, segment and other guidance for 2021; cost synergies,
integration expenses, tax rate, average shares outstanding, capital expenditures and other supplemental financial information for 2021; statements regarding margin expansion, increased target
cost synergies, free cash flow target, potential share repurchase amounts, focused portfolio shaping, innovation and priority R&D investments, capital returns; program, contract and order
opportunities and awards and the value or potential value and timing thereof (including from revenue synergies); and other statements regarding outlook or that are not historical facts. The
company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters
expressed in or implied by such forward-looking statements. The company's consolidated results, future trends and forward-looking statements could be affected by many factors, risks and
uncertainties, including but not limited to: actual impacts related to COVID; risks related to disruption of management time from ongoing business operations due to the combination of L3 and
Harris; risks related to the inability to realize benefits or to implement integration plans and other consequences associated with the combination; the risk that any announcements relating to the
combination could have adverse effects on the market price of the company’s common stock; the risk that the combination could have an adverse effect on the company’s ability to retain
customers and retain and hire key personnel and maintain relationships with suppliers and customers, including the U.S. Government and other governments, and on its operating results and
businesses generally; the loss of the company’s relationship with the U.S. Government or a change or reduction in U.S. Government funding; potential changes in U.S. Government or customer
priorities and requirements (including potential deferrals of awards, terminations, reductions of expenditures, changes to respond to the priorities of Congress and the Administration, budgetary
investor_presentation
R1 RCM
Phibro Animal Health (PAHC) 2022 Company Overview
investor_presentationinvestor_presentation
30 Pages
Phibro Animal Health Corporation
constraints, debt ceiling implications, sequestration, and cost-cutting initiatives); a security breach, through cyber attack or otherwise, or other significant disruptions of the company’s IT networks
Preview truncated — download the full document for the complete content.
earnings
15 Pages